Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease

by Paul W. Jones
Published 2015-06-01

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease

by James F Donohue, Paul W Jones
Published 2011-01-01

Disruption of white matter connectivity in chronic obstructive pulmonary disease.

by Catherine A Spilling, Paul W Jones, James W Dodd, Thomas R Barrick
Published 2019-01-01

Long-term outcomes following first short-term clinically important deterioration in COPD

by Ian P. Naya, Lee Tombs, Hana Muellerova, Christopher Compton, Paul W. Jones
Published 2018-11-01

White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not

by Catherine A. Spilling, Paul W. Jones, James W. Dodd, Thomas R. Barrick
Published 2017-06-01

Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis

by Yogesh Suresh Punekar, Sheetal Sharma, Ankit Pahwa, Jitender Takyar, Ian Naya, Paul W. Jones
Published 2017-05-01

Measuring disease activity in COPD: is clinically important deterioration the answer?

by Dave Singh, Gerard J. Criner, Ian Naya, Paul W. Jones, Lee Tombs, David A. Lipson, MeiLan K. Han
Published 2020-06-01

Early and sustained symptom improvement with umeclidinium/vilanterol monotherapy in COPD: a analysis of the EMAX randomised controlled trial

by Edward M Kerwin, Isabelle H Boucot, Claus F Vogelmeier, Francois Maltais, Ian P Naya, Lee Tombs, Paul W Jones, David A Lipson, Tom Keeley, Leif Bjermer
Published 2020-05-01

Impact of baseline COPD symptom severity on the benefit from dual mono-bronchodilators: an analysis of the EMAX randomised controlled trial

by Claus F. Vogelmeier, Edward M. Kerwin, Leif H. Bjermer, Lee Tombs, Paul W. Jones, Isabelle H. Boucot, Ian P. Naya, David A. Lipson, Chris Compton, Neil Barnes, François Maltais
Published 2020-11-01

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised tr...

by François Maltais, Leif Bjermer, Edward M. Kerwin, Paul W. Jones, Michael L. Watkins, Lee Tombs, Ian P. Naya, Isabelle H. Boucot, David A. Lipson, Chris Compton, Mitra Vahdati-Bolouri, Claus F. Vogelmeier
Published 2019-10-01

Protocol for an observational study to identify potential predictors of an acute exacerbation in patients with chronic obstructive pulmonary disease (the PACE Study)

by Klaus Kenn, Paul W Jones, Rainer Gloeckl, Daniela Leitl, Tessa Schneeberger, Inga Jarosch, Wolfgang Hitzl, Peter Alter, Bernd Sczepanski, Sandra Winterkamp, Martina Boensch, Chrysanthi Skevaki, Olaf Holz, Claus F Vogelmeier, Andreas R Koczulla
Published 2021-02-01

Amygdala Nuclei Volumes Are Selectively Associated With Social Network Size in Homeless and Precariously Housed Persons

by Paul W. Jones, Allen E. Thornton, Andrea A. Jones, Verena M. Knerich, Donna J. Lang, Melissa L. Woodward, William J. Panenka, Wayne Su, Alasdair M. Barr, Tari Buchanan, William G. Honer, Kristina M. Gicas, Kristina M. Gicas
Published 2020-06-01

Component Processes of Decision Making in a Community Sample of Precariously Housed Persons: Associations With Learning and Memory, and Health-Risk Behaviors

by Heather A. Baitz, Heather A. Baitz, Heather A. Baitz, Paul W. Jones, Paul W. Jones, David A. Campbell, David A. Campbell, Andrea A. Jones, Andrea A. Jones, Kristina M. Gicas, Kristina M. Gicas, Kristina M. Gicas, Chantelle J. Giesbrecht, Chantelle J. Giesbrecht, Wendy Loken Thornton, Carmelina C. Barone, Nena Y. Wang, Nena Y. Wang, William J. Panenka, William J. Panenka, Donna J. Lang, Donna J. Lang, Fidel Vila-Rodriguez, Olga Leonova, Alasdair M. Barr, Alasdair M. Barr, Ric M. Procyshyn, Ric M. Procyshyn, Tari Buchanan, Alexander Rauscher, G. William MacEwan, William G. Honer, William G. Honer, Allen E. Thornton, Allen E. Thornton
Published 2021-07-01

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD

by Bartolome R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Alvar A. Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre-Regis Burgel, Peter M. Calverley, Ciro Casanova, Enrico M. Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel J. Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew Fisher, Monica J. Fletcher, Maurice Hayot, John R. Hurst, Paul W. Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martinez, Marc Miravitlles, Paula M. Meek, Alberto Papi, Klaus F. Rabe, Nicolas Roche, Frank C. Sciurba, Sanjay Sethi, Nikos Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jorgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.M. Wouters, Richard L. ZuWallack
Published 2015-06-01